SCHEMBL3243547

SCHEMBL3243547

CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(F)ccc(F)c1Cl

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 11/20 0.90
▸ JAK2 O60674 7/20 0.90
▸ MAP4K3 Q8IVH8 7/20 0.90
▸ ALK Q9UM73 6/20 0.90
▸ JAK3 P52333 4/20 0.90
▸ JAK1 P23458 3/20 0.90
▸ TYK2 P29597 3/20 0.90
▸ PLK4 O00444 2/20 0.90
▸ AURKA O14965 2/20 0.90
▸ DCLK1 O15075 2/20 0.90
▸ PRKD3 O94806 2/20 0.90
▸ ABL1 P00519 2/20 0.90
▸ NTRK1 P04629 2/20 0.90
▸ INSR P06213 2/20 0.90
▸ LCK P06239 2/20 0.90
▸ FES P07332 2/20 0.90
▸ CSF1R P07333 2/20 0.90
▸ LYN P07948 2/20 0.90
▸ RET P07949 2/20 0.90
▸ IGF1R P08069 2/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1582209 1.00 MET (0.90) METJAK2MAP4K3ALKJAK3
Acetic Acid SCHEMBL16324188 0.95 MET (0.82) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL28844303 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL30129754 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL94020 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL29831970 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL28844302 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL29351506 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL93829 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3
Crizotinib SCHEMBL29622387 0.95 MET (1.00) METJAK2MAP4K3ALKJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786785-B9 ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS PFIZER (US) 2013-05-22 — — EP disclosed
EP-1784396-B1 PYRAZOLE-SUBSTITUTED AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS PFIZER (US) 2010-12-22 — — EP disclosed
EP-1786785-B1 ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS PFIZER (US) 2010-04-07 — — EP disclosed
Send feedback